Objective: To examine whether the insulin receptor (INSR) gene contributes to genetic susceptibility to the polycystic ovary syndrome (PCOS). Design: Case-control study. Setting: Academic endocrinology clinic. Patient(s): Ninety-nine women with PCOS as defined by the National Institutes of Health consensus and polycystic ovaries on ultrasonography, and 136 healthy controls. Main Outcome Measure(s): Frequency of genotypes of a single nucleotide polymorphism of the INSR gene in patients and controls. Result(s): After stratification of participants by body mass index, the frequency of the uncommon T allele of the INSR single nucleotide polymorphism was significantly increased in lean patients with PCOS (body mass index ≤27 kg/m2) compared with lean controls (relative risk, 2.1). Conclusion(s): The INSR gene is a susceptibility gene for PCOS among lean patients with PCOS. It remains to be determined whether the exon 17 C/T single nucleotide polymorphism is the susceptibility single nucleotide polymorphism for PCOS or whether it is in linkage disequilibrium with another INSR gene polymorphism. © 2002 by American Society for Reproductive Medicine.
Siegel, S., Futterweit, W., Davies, T. F., Concepcion, E. S., Greenberg, D. A., Villanueva, R., & Tomer, Y. (2002). A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome. Fertility and Sterility, 78(6), 1240–1243. https://doi.org/10.1016/S0015-0282(02)04241-3